Posted on August 1, 2008 by crimsoncanary
Administation of phosphatidylinositol 3-kinase (PI3K) inhibitor LY-294002 to glioblastoma cells sensitized the cells to death receptor and chemotherapy-induced apoptosis
Filed under: kinase | Tagged: Lilly, LY-294002, LY294002, PI3K, Preclinical, Research | Comments Off
Posted on August 1, 2008 by crimsoncanary
Phase II data in metastatic colorectal cancer patients has shown that the addition of gefitinib to FOLFIRI (5-fluorouracil, folinic acid, irinotecan) does not improve outcomes.
Filed under: kinase | Tagged: AstraZeneca, EGF kinase, gefitinib, Iressa, Phase II | Comments Off
Posted on August 1, 2008 by crimsoncanary
MitoSciences have announced an agreement with Roche to generate mitochondrial toxicity profiles for over 100 known kinase inhibitors.
Filed under: kinase | Tagged: kinase, MitoSciences, Preclinical, Research, Roche | Comments Off